Post job

Saol Therapeutics's revenue is $2.2 million.

What is Saol Therapeutics's revenue?

Saol Therapeutics's annual revenue is $2.2M. Zippia's data science team found the following key financial metrics about Saol Therapeutics after extensive research and analysis.
  • Saol Therapeutics has 66 employees, and the revenue per employee ratio is $33,333.
  • Saol Therapeutics peak revenue was $2.2M in 2024.

On this page

Peak revenue
$2.2M (2024)
Company peak revenue
Revenue / employee
$33,333
Company revenue / employee

Zippi applies for you, and finds you a job.

Floating question marks illustration
Peak revenue
$2.2M (2024)
Company peak revenue
Revenue / employee
$33,333
Company revenue / employee

Saol Therapeutics financing

Saol Therapeutics received early financing of $16.7M on 2019-08-05.

SeriesRound sizeDate
Series Unknown$16.7M08/2019

Saol Therapeutics competitors

Saol Therapeutics's top competitor, Rain Therapeutics, earned an annual revenue of $12.5B.

Saol Therapeutics's smallest competitor is Edgewise Therapeutics with revenue of $30.0K last year.

Company nameAverage salaryRevenueEmployee sizeJob openings
JDP Therapeutics-$820,00030-
Supernus Pharmaceuticals-$661.8M448-
Lumos Pharma-$2.1M20-
Tarsa Therapeutics-$1.6M10-
G1 Therapeutics-$82.5M148-
Aquestive Therapeutics-$57.6M100-
Rain Therapeutics-$12.5B17-
Soligenix-$2.4M14-
BridgeBio-$221.9M396-
Accera-$5.5M75-

Saol Therapeutics revenue FAQs

Search for jobs

Zippia gives an in-depth look into the details of Saol Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Saol Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Saol Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Saol Therapeutics. The data presented on this page does not represent the view of Saol Therapeutics and its employees or that of Zippia.

Saol Therapeutics may also be known as or be related to Saol Holdings LLC and Saol Therapeutics.